Philippine bill calls for microbicide development
This article was originally published in Scrip
A bill has been filed with the Philippines House of Representatives calling for the development of microbicidal products to prevent sexually transmitted diseases (STDs). Representative Narciso Santiago pointed to the large social and economic burden of STDs in the country, where the most common infections include HIV/AIDS, hepatitis B, herpes and the human papilloma virus. The bill calls for the department of health to carry out more studies into mechanisms of infection and to develop animal testing models, and for other research into products, delivery systems and their use.
You may also be interested in...
Corporate consolidation and specialization were major threads running through the 2010s in Japan. Reimbursement pricing issues continued to dominate the policy sphere while new forms of therapy benefited from positive regulatory reforms.
BeiGene licenses antibody therapeutics for Castleman’s disease and high-risk neuroblastoma.
BeiGene’s license agreement with Leap Therapeutics covers Asia, except for Japan, along with Australia and New Zealand. Apollomics obtains rights in China and beyond to GlycoMimetics’ e-selectin antagonists.